BridgeBio Pharma maintained as Outperform by Mizuho
Mizuho maintained its Outperform rating on BridgeBio Pharma.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.
Mizuho maintained its Outperform rating on BridgeBio Pharma.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.